Villere St Denis J & Co LLC / ABT
Villere St Denis J & Co LLC’s Abbott Laboratories Position
Does Villere St Denis J & Co LLC own Abbott Laboratories (ABT)? Yes — 230.5K shares worth $24M (+2.61% of its 13F portfolio) as of Q1 2026, down from 231.4K shares the prior filed quarter.
Position Value
$24M
Q1 2026
Shares
230.5K
% of Portfolio
+2.61%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 230.5K | $24M | +2.61% |
| Q4 2025 | 231.4K | $29M | +2.91% |
| Q3 2025 | 235.8K | $32M | +3.04% |
| Q2 2025 | 239.3K | $33M | +3.13% |
| Q1 2025 | 244.5K | $32M | +3.13% |
| Q4 2024 | 242.2K | $27M | +2.47% |
| Q3 2024 | 251.7K | $29M | +2.34% |
| Q2 2024 | 256.3K | $27M | +2.25% |
| Q1 2024 | 256.3K | $29M | +2.32% |
| Q4 2023 | 180.5K | $20M | +1.64% |
| Q3 2023 | 199.1K | $19M | +1.64% |
| Q2 2023 | 202.9K | $22M | +1.60% |
| Q1 2023 | 205.6K | $21M | +1.51% |
| Q4 2022 | 206.0K | $22,620 | +1.77% |
| Q3 2022 | 209.7K | $20M | +1.61% |
| Q2 2022 | 209.8K | $23M | +1.70% |
| Q1 2022 | 207.5K | $25M | +1.46% |
| Q4 2021 | 189.7K | $27M | +1.53% |
| Q3 2021 | 197.9K | $23M | +1.36% |
| Q2 2021 | 200.4K | $23M | +1.24% |
| Q1 2021 | 201.1K | $24M | +1.32% |
| Q4 2020 | 204.0K | $22M | +1.35% |
| Q3 2020 | 205.8K | $22M | +1.51% |
| Q2 2020 | 203.6K | $19M | +1.33% |
| Q1 2020 | 207.7K | $16M | +1.40% |
| Q4 2019 | 208.1K | $18M | +1.18% |
| Q3 2019 | 208.4K | $17M | +1.17% |
| Q2 2019 | 208.5K | $18M | +1.08% |
| Q1 2019 | 211.7K | $17M | +1.11% |
| Q4 2018 | 205.8K | $15M | +1.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Villere St Denis J & Co LLC’s full portfolio or all institutional holders of ABT.